Log in to search using one of your social media accounts:


FDA panel recommends dropping serious warning on Pfizer's Chantix

(Reuters) - A serious warning on Pfizer Inc's quit smoking drug should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data on the controversial treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

More News: Chantix | Food and Drug Administration (FDA) | Health | Pfizer | Smokers | Warnings